Contravisory Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.85M | Sell |
76,643
-655
| -0.8% | -$76.7K | 1.74% | 20 |
|
|
2026
Q1 | $9.3M | Buy |
77,298
+6,385
| +9% | +$737K | 1.91% | 13 |
|
|
2025
Q4 | $7.46M | Buy |
70,913
+70,550
| +19,435% | +$6.62M | 1.48% | 34 |
|
|
2025
Q3 | $30.5K | Sell |
363
-320
| -47% | -$26.4K | 0.01% | 286 |
|
|
2025
Q2 | $54.1K | Sell |
683
-400
| -37% | -$31.8K | 0.01% | 277 |
|
|
2025
Q1 | $97.2K | Buy |
+1,083
| New | +$101K | 0.02% | 269 |
|
|
2024
Q1 | – | Sell |
-74,277
| Closed | -$8.1M | – | 374 |
|
|
2023
Q4 | $8.1M | Sell |
74,277
-657
| -0.9% | -$68.2K | 1.98% | 14 |
|
|
2023
Q3 | $7.71M | Sell |
74,934
-3,146
| -4% | -$339K | 2.18% | 9 |
|
|
2023
Q2 | $9.01M | Buy |
78,080
+522
| +0.7% | +$59.3K | 2.38% | 4 |
|
|
2023
Q1 | $8.25M | Sell |
77,558
-1,074
| -1% | -$116K | 2.33% | 6 |
|
|
2022
Q4 | $8.72M | Buy |
78,632
+4,511
| +6% | +$461K | 2.42% | 7 |
|
|
2022
Q3 | $6.38M | Sell |
74,121
-327
| -0.4% | -$29.2K | 2.13% | 10 |
|
|
2022
Q2 | $6.79M | Buy |
74,448
+74,188
| +28,534% | +$6.58M | 2.2% | 9 |
|
|
2022
Q1 | $21K | Buy |
+260
| New | +$20.5K | 0.01% | 254 |
|
|
2020
Q2 | – | Sell |
-1,183
| Closed | -$87K | – | 309 |
|
|
2020
Q1 | $87K | Hold |
1,183
| – | – | 0.04% | 185 |
|
|
2019
Q4 | $103K | Buy |
1,183
+135
| +13% | +$11.1K | 0.04% | 184 |
|
|
2019
Q3 | $84K | Buy |
1,048
+149
| +17% | +$11.9K | 0.03% | 187 |
|
|
2019
Q2 | $72K | Buy |
899
+148
| +20% | +$11.3K | 0.03% | 186 |
|
|
2019
Q1 | $60K | Buy |
751
+67
| +10% | +$5.01K | 0.02% | 198 |
|
|
2018
Q4 | $50K | Buy |
684
+445
| +186% | +$31.4K | 0.02% | 197 |
|
|
2018
Q3 | $16K | Buy |
+239
| New | +$15.2K | 0.01% | 225 |
|
|
2018
Q1 | – | Sell |
-8
| Closed | – | – | 409 |
|
|
2017
Q4 | $0 | Sell |
8
-253
| -97% | -$14K | ﹤0.01% | 491 |
|
|
2017
Q3 | $16K | Buy |
+261
| New | +$15.8K | 0.01% | 247 |
|
|
2017
Q2 | – | Sell |
-51
| Closed | -$3K | – | 214 |
|
|
2017
Q1 | $3K | Hold |
51
| – | – | ﹤0.01% | 247 |
|
|
2016
Q4 | $3K | Hold |
51
| – | – | ﹤0.01% | 242 |
|
|
2016
Q3 | $3K | Buy |
+51
| New | +$2.98K | ﹤0.01% | 233 |
|
|
2015
Q4 | – | Sell |
-189,226
| Closed | -$8.92M | – | 228 |
|
|
2015
Q3 | $8.92M | Sell |
189,226
-830
| -0.4% | -$44.1K | 2.1% | 28 |
|
|
2015
Q2 | $10.3M | Sell |
190,056
-10,068
| -5% | -$565K | 2.25% | 22 |
|
|
2015
Q1 | $11M | Buy |
200,124
+1,850
| +0.9% | +$105K | 2.2% | 26 |
|
|
2014
Q4 | $10.7M | Sell |
198,274
-2,843
| -1% | -$158K | 2.17% | 31 |
|
|
2014
Q3 | $11.4M | Buy |
+201,117
| New | +$11.3M | 2.37% | 23 |
|
|
2014
Q2 | – | Sell |
-367
| Closed | -$20K | – | 169 |
|
|
2014
Q1 | $20K | Buy |
+367
| New | +$19K | ﹤0.01% | 107 |
|
Other funds holding MRK
LMFP
ATO
AAMU
Contravisory Investment Management's MRK Position: Q2 2026 in Review
Contravisory Investment Management reduced its Merck (MRK) stake by 0.85% in Q2 2026, selling an estimated $76.7K and leaving 76,643 shares worth $9.85M. The position accounts for 1.74% of the portfolio, ranked #20.
Contravisory Investment Management first reported a position in MRK in Q1 2014 and has held it in 32 quarters since. The position peaked at $11.4M in Q3 2014. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Contravisory Investment Management held 76,643 shares of Merck worth $9.85M as of Q2 2026.
- Contravisory Investment Management sold 655 Merck shares in Q2 2026, an estimated $76.7K.
- Merck made up 1.74% of Contravisory Investment Management's portfolio in Q2 2026, its #20 holding.
- Contravisory Investment Management first reported a position in Merck in Q1 2014 and has held it in 32 quarters since.
- Contravisory Investment Management's Merck position peaked at $11.4M in Q3 2014.
- 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.